Latest edition of The World Medical Markets Fact Book 2012!

Puts thousands of key medical market statistics and trends at your fingertips – now with analysis by medical technology sectors

In these challenging economic times the need to understand world medical markets and be able to answer quickly those questions that arise daily is essential.  That is why an authoritative, current and comprehensive market intelligence and statistics source is an invaluable aid for every industry executive.  And that source is the best-selling The World Medical Markets Fact Book 2012

Completely revised and updated for 2012, this highly-detailed and market-leading business reference draws from a vast range of primary national/international government and commercial sources to provide a comprehensive range of hard-to-find business information on the markets for medical devices worldwide.

THE NEW, IMPROVED AND EXPANDED 2012 FACT BOOK BRINGS THE WORLD TO YOU

• Comprehensive coverage of 66 markets around the world
• Five years (2006-2011) data and trend analysis by key medical technology sector (eg Diagnostic Imaging, Patient Aids)
• Five years (2006-2011) data and trend analysis for key market indicators

- Demography (eg population, growth, life expectancy)
- Economic (eg health expenditure)
- Healthcare infrastructure and personnel (eg hospitals, beds, surgical procedures)

• Rankings and overview for the world and 5 major regions
• Individual country statistics
• Over 500 detailed tables and charts

AN EXCELLENT NEW BENEFIT: ALL CUSTOMERS CAN ACCESS THE FACT FILE IN ESPICOM INTERACTIVE

The Fact Book is rich in tables and charts, and with Espicom Interactive online you can access and use this key data easily.  All tables can be instantly exported to MS Excel™ and Charts to MS PowerPoint™ while the fast search quickly pinpoints the data you need.  Best of all, Espicom Interactive is included in the report’s price!

THE FACT BOOK ANSWERS KEY BUSINESS QUESTIONS SUCH AS…

• Which country spends most on medical devices as a % of GDP?
• How are the economic downturn and currency fluctuations affecting key markets?
• Which medical device sectors are growing the fastest?
• How does the Brazilian market compare with China and India in terms of total health expenditure?
• What demographic development is affecting the market in Central and Eastern Europe?
• What have been the key trends affecting medical technology companies in leading emerging Latin American Markets?

ORDER YOUR COPY TODAY WITH ESPICOM INTERACTIVE INCLUDED IN THE PRICE!

For more information or to order a copy of this report please visit www.espicom.com/mfb

New report: The Global Advanced Wound Care Market to 2017

As the advanced wound care market tops US$5.5 billion, private finance and pharma are playing an increasingly influential role in its development.  What does it mean for the sector?

Mergers and acquisitions have always played a key role in the advanced wound care industry and have enabled the market leaders to expand their technology to address new sections of the market and provide access to new technologies.  But things are hotting up.  Smith & Nephew continues to add to its portfolio with the acquisition in May 2012 of Kalypto Medical while pharmaceutical companies flex their financial muscle: Shire purchased BioHealing in June 2011 while Sanofi purchased Genzyme in April 2011.

Private equity is getting more involved in the sector.  The headline acquisition of the NPWT leading company KCI by the APAX consortium is just the latest of a string of private equity transactions.  Nordic Capital and Avista Capital Partners purchased ConvaTec in August 2008, Systagenix was formed in December 2008 through One Equity Partners’ purchase of Ethicon Professional Wound Care, and Investor AB took full control of Mölnlycke in late 2010.

But what of the future?  With price pressures in the NPWT sector and low prices driven by high competition in the Moist Dressings sector, the spotlight has been thrown on Biologics.  While all sectors are expected to return to stronger annual growth, only the Biologics sector is expected to maintain double digit growth from 2015 onwards as products currently in development are launched.

THIS NEW (JULY 2012) MARKET RESEARCH REPORT PROVIDES A COMPLETE REVIEW AND ANALYSIS

• Extensive competitive and product analysis of 109 major and emerging companies
• Market share for leading companies
• Growth forecasts and market share to 2017 by principal product area and geographical region

THE REPORT ANSWERS KEY BUSINESS QUESTIONS SUCH AS…

• What next for Kinetic Concepts after its litigation troubles?
• What % of the European market will moist dressings account for in 2017?
• Who’s developing products in the skin substitution market?
• Who’s partnering whom, and on what?
• Which are the companies and technologies to watch?

ALL ADVANCED WOUND CARE SECTORS ARE COVERED INCLUDING:

Device-based advanced wound care

• Negative Pressure Wound Therapy
• Electrical Stimulation
• Ultrasound
• Extracorporeal Shock Wave Therapy

Moist wound care

• Hydrogels
• Hydrocolloid Dressings
• Alginates
• Foam Dressings
• Composite Dressings
• Activated Charcoal Dressings
• Transparent Film Dressings
• Antimicrobial Dressings
• Silver Dressings

Biologics

• Collagen-Based Wound Care Products
• Skin Substitutes
• Growth Factors
• Cell-Based Therapies
• Enzymatic Debriding Agents

 A NEW, REALLY USEFUL AND FREE BENEFIT: ESPICOM INTERACTIVE

This report is rich in tables and charts, and with Espicom Interactive online you can access and use this key data easily.  All tables can be instantly exported to MS Excel™ and Charts to MS PowerPoint™ while the fast search quickly pinpoints the data and information you need.  Support agents and overseas colleagues with instant translation into 9 languages. And best of all? Espicom Interactive is included in the report’s price!

ORDER YOUR COPY TODAY

You can buy your copy of The Global Advanced Wound Care Market to 2017 now.  For further information on the report’s extensive contents, please click here(www.espicom.com/awc).  Please note that prepayment is not required on this report.

Visit www.espicom.com to view all of our latest products.

New report published – Cardiovascular Device Companies: Surveying the Global Competitive Landscape

This week sees the release of a new report published by Espicom Business Intelligence entitled Cardiovascular Device Companies – Surveying the global competitive landscape.

Whilst it doesn’t take a genius to conclude that the cardiovascular device market is a fast changing industry, it’s often very difficult to view these changes close up. It’s been seven years since we produced our first report focused on the Cardiovascular sector, and those changes keep on coming as we head towards 2013.

For a period of time, much of the focus was all about drug-eluting stents, and for a while at least the technology looked like fulfilling its potential. In truth, the technology has faced a perfect storm of bad news that has dogged its progress. First up, there was the pricing and cost-effective issue, then came subsequently panned EU data that suggested restenosis rates were just too high and last of all, this seemingly relentless worldwide recession came along and neatly priced potential customers out of the technology.

Last year came the unexpected news that continued declines in DES sales had persuaded Cordis to quit the industry. But it’s not all doom and gloom because the removal of a major competitor might actually reduce overcapacity in the sector. Technological improvements have come in the form of biodegradeable DESs and lessons have been learned in terms of product development and research.

The issue of reabsorbable DESs also features in the report overview section – a 14-page look at the regulatory climate in the US and in Europe. As Abbott stands poised to get marketing approval for its Absorb bioabsorbable vascular scaffold more than 18 months after European authorities gave its approval, we examine whether the FDA needs to more to bridge this gap or whether the EU system is just too quick for its own good.

It’s not just DESs that are the focus of attention. Edwards Lifesciences is also enjoying the fruits of long-term research and working its way through the somewhat unpredictable FDA pathway to get commercial release of its Sapien transcatheter heart valve. And boy, is the cash rolling in for the company in the US, where it dominates the market! Last year, transcatheter heart valve sales for Edwards jumped by over 60 per cent and now total US$334 million. That technology seems to have taken an age to get to the US market and some say the delay has effectively cost thousands of lives that could have been saved. Strong criticism indeed!

A detailed review of over 60 companies

This year the report has 60 companies that span the full breadth of the cardiovascular device field, ranging from cardiac rhythm management to interventional cardiology. Interestingly, after a long period of research and product fine tuning, the market for cardiac assist devices, such as ventricular assist devices, implantable heart replacement devices and other similar devices look to be approaching the first stage in the commercial endgame. The tell-tale sign is further consolidation within the industry and the focus on building a body of data to support the longevity of respective technologies.

One cannot also forget the rising profile of the renal denervation system, which represents a non-drug treatment option for hypertension. A reduction in systolic blood pressure, a function that underpins the technology, has cut incidents of stroke, heart disease and mortality. Most of the big players – including St Jude Medical and Medtronic – are working on significant trials of the devices, but it is also being driven by much smaller companies that want a slice of the action.

So there’s a lot to read – and a lot to take in and consider – about this year in our newly updated, and ever changing Cardiovascular Device Companies – Surveying the global competitive landscape report.

For more information regarding this report visit www.espicom.com/cdev

In the light of recent world developments, Espicom Business Intelligence has just released a new report entitled The Libyan Medical Market: Status & Post-Conflict Opportunities. This report has been compiled from novel forecasts and original materials to give a complete overview of the Libyan health market. Together with the fall of the Gaddafi regime as well as the expected introduction of a more open-handed democratic government, it is time to scrutinize Libya’s medical market economy in the region, examine the way it may develop, and assess the impacts for medical technology companies.

Libya is a small but oil-rich country in North Africa. Under the personal rule of Muammar Gaddafi from 1969 to 2011, it developed an eccentric mixture of socialism and Islam. The country was largely isolated from the international community due to its terrorist links, although Gaddafi made concerted and largely successful moves to re-engage with the West in the 2001-10 period.

2011 saw a bloody but ultimately successful rebellion against Gaddafi’s rule, caused by declining living standards over the past two years, and inspired by the Arab Spring uprisings in neighbouring countries such as Egypt and Tunisia. Aided by NATO airpower, anti-Gaddafi forces based in Libya’s second city, Benghazi, were able to take Tripoli in August 2011, and the whole country by October.

Libya’s oil wealth has enabled it to create a reasonably comprehensive healthcare system, but spending remains low in comparison with other oil-rich countries of comparable income such as Saudi Arabia. There is therefore considerable scope for expansion and modernisation in the future. There is no private insurance as such, so local people are largely reliant on the public hospital system. There is a well-equipped private sector, which caters for wealthier locals and workers in the oil industry.

The 2011 fighting has caused serious dislocation in the health sector, at the same time as placing great strains upon it. Some facilities have been directly damaged, while others have faced shortages of power, equipment, supplies and personnel. Most services have remained open, however, and the transitional council in Benghazi established a health ministry early on, in order to restore some normality. Shortages have become far less acute in the latter part of 2011, helped by short term overseas aid and the unlocking of public funds for use by the transitional government.

Libya makes some drugs locally, but has no significant domestic production of medical equipment, so all its requirements have to be met by imports. These were boosted by the thawing of relations with the EU and USA in 2003-04, since when direct trade became far easier. Imports peaked at just under US$200 million in 2009, but fell back in 2010 to US$146 million or US$22 per capita. Around three quarters is sourced from the EU, principally Germany and Italy. Despite the fall in 2010, Libya remains by some margin the leading African importer of medical equipment in per capita terms, ahead of larger economies such as South Africa or Egypt.

Understandably, the fighting in 2011 had a severe effect on the Libyan medical market. Imports shrank to almost nothing in the March to July period when trade became difficult, not least due to the freezing of government finance. With the fall of Tripoli in August and the death of Gaddafi in October, some much-needed stability has returned and a rapid rebound to pre-2011 levels of spending can be expected as the new government – and the private sector – restock and re-equip. Looking further forward, Libya has the opportunity to use its oil wealth to create a sophisticated and advanced health sector in the style of the Gulf states, assuming a degree of political will and ongoing political stability. The latter is far from a certainty, but the prospects appear far brighter post-Gaddafi than under his rule.

To purchase, or read more on this new report please click on the link to The Libyan Medical Market: Status & Post-Conflict Opportunities.

Related articles

• Medica 2011 (medical-technologyblog.com)
• New Interactive Dashboard for Medical Market Research! (medical-technologyblog.com)
• Medical Industry Week – Wireless Technology & Apps for Medical Devices (medical-technologyblog.com)

In today’s post on the Medical Technology Blog,  is a list of Espicom’s most recent reports from July to the present day, I have included our Pharmaceutical reports as well in case there’s an area of interest for anyone, please click on the links below to be taken to the relevant report page;

Medical:

1. Global Advanced Wound Care Market to 2015 – Competitor Analysis *

2. Orthopaedics – Surveying the Global Orthopaedics Market Landscape *

3. Who’s Developing What in Cardiovascular Devices in 2010

4. Orthopaedic Markets in Western Europe 2010

5. The Global Market for Orthobiologic Products

6. The African Medical Device Market: Facts and Figures 2010

7. Effectively Selling Medical Equipment in Western Europe

8. The World Medical Markets Fact Book 2010

9. World Medical Market Forecasts to 2015

10. All Change in the Coronary Stent Market

* Denotes latest reports

Pharmaceutical:

1. Global Biosimilars: Identifying 2nd Generation Opportunities *

2. Drug Delivery – Surveying the Global Competitive Landscape *

3. Pharmaceutical Companies Performance Tables 2010 *

4. Cancer Drug Blockbusters – Prospects & Challenges for Cancer Drugs

5. Multiple Sclerosis Drug Discoveries – What the Future Holds

6. Epigenetics – Current & Future Applications

7. MRSA Drug Futures

8. Biomarkers – Applications & Trends

9. The World Pharmaceutical Markets Fact Book 2010

10. Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

11. The Indian Pharmaceutical Industry 2010: Strategies in a Changing World

* Denotes latest reports

Thanks for reading, Paul Espicom Business Intelligence.

Do you have a medical technology subject or device that you would  like a report or article written for? If so contact me directly at paul_hoff@espicom.com

Related articles

• How Will Potential Changes to Pharmaceutical Pricing affect Drug Consumption? (thepharmaceutical-news.com)
• How is the Current Macroenvironment in Austria Affecting the Pharmaceutical Market? (thepharmaceutical-news.com)
• What Impact has the Recent Flooding Disaster had on the Macroenvironment for the Pharmaceutical Market in Pakistan? (thepharmaceutical-news.com)

In today’s post on the Medical Technology Blog,  is a list of Espicom’s most recent reports from July to the present day, I have included our Pharmaceutical reports as well in case there’s an area of interest for anyone, please click on the links below to be taken to the relevant report page;

Medical:

1. Global Advanced Wound Care Market to 2015 – Competitor Analysis *

2. Orthopaedics – Surveying the Global Orthopaedics Market Landscape *

3. Who’s Developing What in Cardiovascular Devices in 2010

4. Orthopaedic Markets in Western Europe 2010

5. The Global Market for Orthobiologic Products

6. The African Medical Device Market: Facts and Figures 2010

7. Effectively Selling Medical Equipment in Western Europe

8. The World Medical Markets Fact Book 2010

9. World Medical Market Forecasts to 2015

10. All Change in the Coronary Stent Market

* Denotes latest reports

Pharmaceutical:

1. Drug Delivery – Surveying the Global Competitive Landscape *

2. Pharmaceutical Companies Performance Tables 2010 *

3. Cancer Drug Blockbusters – Prospects & Challenges for Cancer Drugs

4. Multiple Sclerosis Drug Discoveries – What the Future Holds

5. Epigenetics – Current & Future Applications

6. MRSA Drug Futures

7. Biomarkers – Applications & Trends

8. The World Pharmaceutical Markets Fact Book 2010

9. Lung Cancer: Global Incidence, Prevalence and Mortality to 2015

10. The Indian Pharmaceutical Industry 2010: Strategies in a Changing World

* Denotes latest reports

Thanks for reading, Paul Espicom Business Intelligence.

Do you have a medical technology subject or device that you would  like a report or article written for? If so contact me directly at paul_hoff@espicom.com

Related articles

• How Will Potential Changes to Pharmaceutical Pricing affect Drug Consumption? (thepharmaceutical-news.com)
• How is the Current Macroenvironment in Austria Affecting the Pharmaceutical Market? (thepharmaceutical-news.com)
• What Impact has the Recent Flooding Disaster had on the Macroenvironment for the Pharmaceutical Market in Pakistan? (thepharmaceutical-news.com)